Isolation and characterisation of Ebolavirus-specific recombinant antibody fragments from murine and shark immune libraries.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Molecular Immunology

• Publication date

  2011-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.molimm.2011.06.437PMID 21752470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Single domain antibodies: promising experimental and therapeutic tools in infection and immunity

  2009cited by this paper
• Molecular and Cellular Basis of Microvascular Perfusion Deficits Induced by Clostridium perfringens and Clostridium septicum

  2008cited by this paper
• Reference Intervals in Healthy Adult Ugandan Blood Donors and Their Impact on Conducting International Vaccine Trials

  2008cited by this paper
• Isolation of anti-toxin single domain antibodies from a semi-synthetic spiny dogfish shark display library

  2007cited by this paper
• Production and characterization of monoclonal antibodies against different epitopes of Ebola virus antigens.

  2007cited by this paper
• Rapid isolation of IgNAR variable single-domain antibody fragments from a shark synthetic library.

  2007cited by this paper
• Selection of cholera toxin specific IgNAR single-domain antibodies from a naïve shark library.

  2007cited by this paper
• Properties, production, and applications of camelid single-domain antibody fragments

  2007cited by this paper
• Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever.

  2007cited by this paper
• Rapid assembly of sensitive antigen-capture assays for Marburg virus, using in vitro selection of llama single-domain antibodies, at biosafety level 4.

  2007cited by this paper
• Antibody repertoire development in cartilaginous fish.

  2006cited by this paper
• First molecular and biochemical analysis of in vivo affinity maturation in an ectothermic vertebrate.

  2006cited by this paper
• Antibody repertoire development in camelids.

  2006cited by this paper
• Isolation and characterization of a thermally stable recombinant anti-caffeine heavy-chain antibody fragment.

  2006cited by this paper
• [Human recombinant antibodies to Ebola virus: preparation and characteristics].

  2005cited by this paper
• Laboratory diagnosis of Ebola and Marburg hemorrhagic fever.

  2005cited by this paper
• Analysis of the expressed heavy chain variable-region genes of Macaca fascicularis and isolation of monoclonal antibodies specific for the Ebola virus' soluble glycoprotein

  2005cited by this paper
• Rapid Diagnosis of Ebola Hemorrhagic Fever by Reverse Transcription-PCR in an Outbreak Setting and Assessment of Patient Viral Load as a Predictor of Outcome

  2004cited by this paper
• Selection and characterization of naturally occurring single-domain (IgNAR) antibody fragments from immunized sharks by phage display.

  2003cited by this paper
• Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection.

  2003cited by this paper
• Serological reactivity of baculovirus-expressed Ebola virus VP35 and nucleoproteins.

  2003cited by this paper
• Development, characterization and use of monoclonal VP40-antibodies for the detection of Ebola virus.

  2003cited by this paper
• Antigen Capture Enzyme-Linked Immunosorbent Assay for Specific Detection of Reston Ebola Virus Nucleoprotein

  2003cited by this paper
• Structural analysis, selection, and ontogeny of the shark new antigen receptor (IgNAR): identification of a new locus preferentially expressed in early development

  2002cited by this paper
• Hemorrhagic fever viruses as biological weapons: medical and public health management.

  2002cited by this paper
• Single‐domain antibody fragments with high conformational stability

  2002cited by this paper
• Enzyme-Linked Immunosorbent Assays for Detection of Antibodies to Ebola and Marburg Viruses Using Recombinant Nucleoproteins

  2001cited by this paper
• Thermal unfolding of a llama antibody fragment: a two-state reversible process.

  2001cited by this paper
• Biological Agents: Weapons of Warfare and Bioterrorism

  2001cited by this paper
• Detection of Ebola Viral Antigen by Enzyme-Linked Immunosorbent Assay Using a Novel Monoclonal Antibody to Nucleoprotein

  2001cited by this paper
• Construction of scFv Fragments from Hybridoma or Spleen Cells by PCR Assembly

  2001cited by this paper
• [Monoclonal antibodies to Ebola virus: isolation, characteristics, and study of cross reactivity with Marburg virus].

  2000cited by this paper
• Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup.

  2000cited by this paper
• Epitopes involved in antibody-mediated protection from Ebola virus.

  2000cited by this paper
• Diagnosis of Ebola haemorrhagic fever by RT‐PCR in an epidemic setting

  2000cited by this paper
• Long-term disease surveillance in Bandundu region, Democratic Republic of the Congo: a model for early detection and prevention of Ebola hemorrhagic fever.

  1999cited by this paper
• Persistence and genetic stability of Ebola virus during the outbreak in Kikwit, Democratic Republic of the Congo, 1995.

  1999cited by this paper
• Clinical virology of Ebola hemorrhagic fever (EHF): virus, virus antigen, and IgG and IgM antibody findings among EHF patients in Kikwit, Democratic Republic of the Congo, 1995.

  1999cited by this paper
• Preparation and use of hyperimmune serum for prophylaxis and therapy of Ebola virus infections.

  1999cited by this paper
• ELISA for the detection of antibodies to Ebola viruses.

  1999cited by this paper
• The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidémies à Kikwit.

  1999cited by this paper
• Clinical, virologic, and immunologic follow-up of convalescent Ebola hemorrhagic fever patients and their household contacts, Kikwit, Democratic Republic of the Congo. Commission de Lutte contre les Epidémies à Kikwit.

  1999cited by this paper
• Stabilization of antibody fragments in adverse environments

  1998cited by this paper
• Somatic hypermutation of the new antigen receptor gene (NAR) in the nurse shark does not generate the repertoire: possible role in antigen-driven reactions in the absence of germinal centers.

  1998cited by this paper
• Recombinant Ebola virus nucleoprotein and glycoprotein (Gabon 94 strain) provide new tools for the detection of human infections.

  1998cited by this paper
• Structural analysis of the nurse shark (new) antigen receptor (NAR): molecular convergence of NAR and unusual mammalian immunoglobulins.

  1998cited by this paper
• Isolation and partial molecular characterisation of a strain of Ebola virus during a recent epidemic of viral haemorrhagic fever in Gabon.

  1997cited by this paper
• Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system.

  1997cited by this paper
• [Development of the immunoenzyme test-system for detection of Ebola virus antigen].

  1996cited by this paper
• Differentiation of filoviruses by electron microscopy.

  1995cited by this paper
• [Development and study of the properties of immunoglobulin against Ebola fever].

  1995cited by this paper
• A new antigen receptor gene family that undergoes rearrangement and extensive somatic diversification in sharks

  1995cited by this paper
• [Development and application of an immunoenzyme test system for diagnosing Ebola fever].

  1995cited by this paper
• Preparation of rabbit antiserum to Ebola virus

  1994cited by this paper
• Antibody fragments from a ‘single pot’ phage display library as immunochemical reagents.

  1994cited by this paper
• [Preparation of rabbit antiserum to Ebola virus].

  1994cited by this paper
• Ebola protein analyses for the determination of genetic organization

  1993cited by this paper
• Naturally occurring antibodies devoid of light chains

  1993cited by this paper
• Enzyme immunosorbent assay for Ebola virus antigens in tissues of infected primates

  1992cited by this paper
• Rapid identification of Ebola virus and related filoviruses in fluid specimens using indirect immunoelectron microscopy.

  1991cited by this paper
• A comparison of strategies to stabilize immunoglobulin Fv-fragments.

  1990cited by this paper
• Ebola and marburg viruses: I. Some ultrastructural differences between strains when grown in vero cells

  1979cited by this paper
• The evolution of the immune response. XI. The immunoglobulins of the horned shark, Heterodontus francisci: purification, characterization and structural requirement for antibody activity.

  1971cited by this paper
• Sharks, Skates, and Rays

  1967cited by this paper
• Immunoglobulins of the leopard shark. I. Isolation and characterization of 17 S and 7 S immunoglobulins with precipitating activity.

  1967cited by this paper
• THE EVOLUTION OF THE IMMUNE RESPONSE

  1964cited by this paper

• VNAR: shark single-domain antibodies for the new era of medical biotechnology

  2026cites this paper
• A shark-derived broadly neutralizing nanobody targeting a highly conserved epitope on the S2 domain of sarbecoviruses

  2025cites this paper
• Non-Ebola Filoviruses: Potential Threats to Global Health Security

  2024cites this paper
• Antibody Phage Display Technology for Sensor-Based Virus Detection: Current Status and Future Prospects

  2023cites this paper
• Screening and anti‐glioma activity of Chiloscyllium plagiosum anti‐human IL‐13Rα2 single‐domain antibody

  2023cites this paper
• Shark nanobodies with potent SARS-CoV-2 neutralizing activity and broad sarbecovirus reactivity

  2023cites this paper
• Shark VNAR phage display libraries: An alternative source for therapeutic and diagnostic recombinant antibody fragments.

  2023cites this paper
• Exploring shark VNAR antibody against infectious diseases using phage display technology.

  2023cites this paper
• Osteoarthritis versus psoriasis arthritis: Physiopathology, cellular signaling, and therapeutic strategies

  2023cites this paper
• Selection of Cancer Stem Cell-Targeting Agents Using Bacteriophage Display.

  2022cites this paper
• Screening and Characterization of Shark-Derived VNARs against SARS-CoV-2 Spike RBD Protein

  2022cites this paper
• A megadiverse naïve library derived from numerous camelids for efficient and rapid development of VHH antibodies.

  2022cites this paper
• Preparation of Immune and Synthetic VNAR Libraries as Sources of High-Affinity Binders.

  2022cites this paper
• Overview, Generation, and Significance of Variable New Antigen Receptors (VNARs) as a Platform for Drug and Diagnostic Development.

  2022cites this paper
• IgNAR antibody: Structural features, diversity and applications.

  2022cites this paper
• Application of Single-Domain Antibodies (“Nanobodies”) to Laboratory Diagnosis

  2021influential citation
• Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy

  2021cites this paper
• A New Approach in DENV Diagnostic based on Linear Peptides Obtained by Phage Display

  2021cites this paper
• Selection and Characterization of Anti-idiotypic Shark Antibody Domains.

  2020cites this paper
• Single-Domain Antibodies: Biology, Engineering and Emerging Applications

  2020cites this paper
• Infectious disease antibodies for biomedical applications: A mini review of immune antibody phage library repertoire

  2020cites this paper
• Diagnostic and therapeutic potential of shark variable new antigen receptor (VNAR) single domain antibody

  2020cites this paper
• Genotype Phenotype Coupling: Methods and Protocols

  2020influential citation
• Cytoplasmic and periplasmic expression of recombinant shark VNAR antibody in Escherichia coli

  2019cites this paper
• Shark IgNAR-derived binding domains as potential diagnostic and therapeutic agents.

  2019cites this paper
• Synthetic libraries of shark vNAR domains with different cysteine numbers within the CDR3

  2019cites this paper
• Advances in the Production and Batch Reformatting of Phage Antibody Libraries

  2019cites this paper
• Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3

  2019cites this paper
• Antibody Structure and Function: The Basis for Engineering Therapeutics

  2019cites this paper
• Isolation of highly selective IgNAR variable single-domains against a human therapeutic Fc scaffold and their application as tailor-made bioprocessing reagents.

  2019cites this paper
• Special Section: From Insight to Modulation of CXCR4 and ACKR3 (CXCR7) Function –Minireview Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3

  2019cites this paper
• Isolation and characterization of malaria PfHRP2 specific VNAR antibody fragments from immunized shark phage display library

  2018cites this paper
• Generation of Semi-Synthetic Shark IgNAR Single-Domain Antibody Libraries.

  2018cites this paper
• The Development of Single Domain Antibodies for Diagnostic and Therapeutic Applications

  2018cites this paper
• Single-domain antibody fragments derived from heavy-chain antibodies: a review

  2018cites this paper
• Construction of Histidine-Enriched Shark IgNAR Variable Domain Antibody Libraries for the Isolation of pH-Sensitive vNAR Fragments.

  2018cites this paper
• The Development of a Drug Delivery System Using Brain Endothelial Non-Antibody Binding Domains as Transport Carriers

  2018cites this paper
• Ultrasensitive detection of Ebola matrix protein in a memristor mode

  2018cites this paper
• Therapeutic Potential of Shark Anti-ICOSL VNAR Domains is Exemplified in a Murine Model of Autoimmune Non-Infectious Uveitis

  2017cites this paper
• Selection, characterization, and thermal stabilization of llama single domain antibodies towards Ebola virus glycoprotein

  2017cites this paper
• Phage Display Derived IgNAR V Region Binding Domains for Therapeutic Development.

  2017cites this paper
• Label free checkerboard assay to determine overlapping epitopes of Ebola virus VP-40 antibodies using surface plasmon resonance.

  2017cites this paper
• Enhancing Stability of Camelid and Shark Single Domain Antibodies: An Overview

  2017cites this paper
• Camelid and shark single domain antibodies: structural features and therapeutic potential.

  2017cites this paper
• From Bits and Pieces to Whole Phage to Nanomachines: Pathogen Detection Using Bacteriophages.

  2017cites this paper
• Single Domain Antibodies as New Biomarker Detectors

  2017cites this paper
• Immune Antibody Libraries: Manipulating The Diverse Immune Repertoire for Antibody Discovery.

  2017cites this paper
• In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties to Facilitate Clinical Development

  2017cites this paper
• Generation of Recombinant Antibodies Against Toxins and Viruses by Phage Display for Diagnostics and Therapy

  2016cites this paper
• Importance of Hypervariable Region 2 for Stability and Affinity of a Shark Single-Domain Antibody Specific for Ebola Virus Nucleoprotein

  2016cites this paper
• The Immune System and Immunity in Cartilaginous Fish

  2016cites this paper
• Editorial: Antibody Phage Display: The Evolution of Antibody Therapeutics.

  2016cites this paper
• Neglected filoviruses.

  2016cites this paper
• i-bodies, Human Single Domain Antibodies That Antagonize Chemokine Receptor CXCR4*

  2016cites this paper
• Protein Targeting Compounds

  2016cites this paper
• Recombinant antibodies for diagnostics and therapy against pathogens and toxins generated by phage display

  2016cites this paper
• Single-domain antibodies for biomedical applications

  2016cites this paper
• Structural and genetic diversity in antibody repertoires from diverse species.

  2015cites this paper
• Advances in phage display technology for drug discovery

  2015cites this paper
• VNARs: An Ancient and Unique Repertoire of Molecules That Deliver Small, Soluble, Stable and High Affinity Binders of Proteins

  2015cites this paper
• Structural insights and biomedical potential of IgNAR scaffolds from sharks

  2014cites this paper
• Shark Attack: high affinity binding proteins derived from shark vNAR domains by stepwise in vitro affinity maturation.

  2014cites this paper
• Shark variable new antigen receptor biologics – a novel technology platform for therapeutic drug development

  2014cites this paper
• Thermal stability and refolding capability of shark derived single domain antibodies.

  2014cites this paper
• What the shark immune system can and cannot provide for the expanding design landscape of immunotherapy

  2014cites this paper
• Engineered Antibody Domains as Candidate Therapeutics

  2014cites this paper
• Monoclonal antibodies for prophylactic and therapeutic use against viral infections

  2013cites this paper
• Monoclonal antibodies for prophylactic and therapeutic use against viral infections

  2013cites this paper
• Ebolavirus Nucleoprotein C-Termini Potently Attract Single Domain Antibodies Enabling Monoclonal Affinity Reagent Sandwich Assay (MARSA) Formulation

  2013influential citation
• eview onoclonal antibodies for prophylactic and therapeutic use against viral

  2013cites this paper
• Variable domain antibodies specific for viral hemorrhagic septicemia virus (VHSV) selected from a randomized IgNAR phage display library.

  2013cites this paper
• Influenza B-cells Protective Epitope Characterization: A Passkey for the Rational Design of New Broad-Range Anti-Influenza Vaccines

  2012cites this paper
• Phage Display-based Strategies for Cloning and Optimization of Monoclonal Antibodies Directed against Human Pathogens

  2012cites this paper
• marine drugs

  year unknowncites this paper